Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane

Linac-based radiotherapy has a negligible effect on the majority of advanced neoplasms. Therefore, a novel radiosensitization treatment Kochi Oxydol Radiation Therapy for Unresectable Carcinomas II (KORTUC II), which utilizes hydrogen peroxide and sodium hyaluronate was developed. The effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Nobutaka, Ogawa, Yasuhiro, Yasuoka, Miki, Iwasa, Hitomi, Miyatake, Kana, Yoshimatsu, Rika, Yamanishi, Tomoaki, Hamada, Norihiko, Tamura, Taiji, Kobayashi, Kana, Murata, Yoriko, Yamagami, Takuji, Miyamura, Mitsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245061/
https://www.ncbi.nlm.nih.gov/pubmed/28123524
http://dx.doi.org/10.3892/ol.2016.5456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245061/
https://www.ncbi.nlm.nih.gov/pubmed/28123524
http://dx.doi.org/10.3892/ol.2016.5456

Ejemplares similares